AI assistant
MEDIFAST INC — Director's Dealing 2022
Apr 21, 2022
33899_dirs_2022-04-21_ab7833c7-0e7d-4c64-9dd9-c4beb003ce30.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2022-02-04
Reporting Person: Chard Daniel R (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-04 | Common Stock | P | 690.274 | $186.40 | Acquired | 103839.274 | Indirect |
| 2022-02-23 | Common Stock | G | 3375 | — | Disposed | 16886 | Direct |
| 2022-02-23 | Common Stock | G | 3375 | — | Acquired | 107214.274 | Indirect |
| 2022-03-21 | Common Stock | G | 953 | — | Disposed | 15933 | Direct |
| 2022-03-21 | Common Stock | G | 953 | — | Acquired | 108167.274 | Indirect |
Footnotes
F1: The shares were acquired by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is Settlor of the Trust and Investment Trustee, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F2: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.
F3: The reporting person transferred these shares to The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.